Gilead, Terray

Gilead, Terray to collaborate on small molecule drugs
Gilead Sciences (GILD) and Terray Therapeutics have entered into a strategic collaboration to discover and develop small molecule therapeutics. Read more here.
Gilead and Terray Therapeutics Announce Multi-Target Research Collaboration to Discover and Develop Novel Small Molecule Therapies
Gilead Sciences, Inc. (Nasdaq: GILD) and Terray Therapeutics, Inc. announced today that the companies have entered into a strategic collaboration to discover and develop novel, small molecule therapies across multiple targets.
Gilead, Terray Therapeutics announce research collaboration
Gilead (GILD) and Terray Therapeutics announced that the companies have entered into a strategic collaboration to discover and develop novel,
Gilead Sciences, Terray Therapeutics Set AI-Powered Research Collaboration
Gilead Sciences is working with AI-powered biotechnology company Terray Therapeutics to use artificial intelligence to discover and develop small-molecule therapies across multiple targets.
Gilead inks multi-target deal with Terray Therapeutics
US antivirals giant Gilead Sciences today revealed it has entered into a strategic collaboration to discover and develop novel, small molecule therapies across multiple targets with Californian biotech Terray Therapeutics.
Gilead Inks Strategic Collaboration With Terray Therapeutics To Develop Small Molecule Therapies
Gilead Sciences, Inc. (GILD) and Terray Therapeutics, Inc. announced Tuesday that the companies have entered into a strategic
FierceBiotech7h
Fresh off $120M raise, AI-powered Terray is teaming up with Gilead in multi-pronged R&D pact
Terray is ending the year on a high. Just two short months ago the biotech came out with a healthy $120 million series B ...
STAT14d
Sanofi pours $1 billion into China for insulin plant
Sanofi just made its largest investment thus far in China. The company has committed just over $1 billion to build a new ...
ExplorersWeb on MSN22d
Remembering Louis Lachenal
In his early 20s, he became a mountaineering and ski instructor and a guide in Chamonix. Lachenal started climbing with ...
Business Wire1mon
Odyssey Therapeutics and Terray Therapeutics Enter Strategic Collaboration to Jointly Discover and Develop First-in-Class Transcription Factor Therapies
The collaboration combines Odyssey’s expertise in immunology and transcription factor biology with Terray’s complementary expertise in immunology and integrated AI platform, tNova, which ...
The Financial Times4mon
How AI and accelerated computing are transforming drug discovery
To empower researchers to explore the chemical space composed of over 10^60 – or novemdecillion – possible drug-like molecules, Terray Therapeutics is harnessing the power of accelerated ...